Tony Ho

Follow

Person

Wilmington, DE, US

People

Patents Grantslast 30 patents

Information Patent Grant
NK3 receptor antagonist compound (NK3RA) for use in a method for th...
- Patent number 9,475,773
- Issue date Oct 25, 2016
- Astrazeneca AB
- Peter Stewart Gilmour
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTI-PD-L1 ANTIBODY TREATMENT OF BLADDER CANCER
- Publication number 20220332828
- Publication date Oct 20, 2022
- Medimmune, LLC
- JOHN KURLAND
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS COMPRISING FIXED INTERMITTENT DOSING OF CEDIRANIB
- Publication number 20210322415
- Publication date Oct 21, 2021
- AstraZeneca AB
- Simon BARRY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PD-L1 ANTIBODY TREATMENT OF BLADDER CANCER
- Publication number 20190359715
- Publication date Nov 28, 2019
- Medimmune, LLC
- JOHN KURLAND
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NK3 RECEPTOR ANTAGONIST COMPOUND (NK3RA) FOR USE IN A METHOD FOR TH...
- Publication number 20170157109
- Publication date Jun 8, 2017
- AstraZeneca AB
- Peter Stewart Gilmour
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
A NK3 RECEPTOR ANTAGONIST COMPOUND (NK3RA) FOR USE IN A METHOD FOR...
- Publication number 20160083350
- Publication date Mar 24, 2016
- AstraZeneca UK Limited
- Peter Stewart Gilmour
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE